Product Description
The 3° Anterior Cervical Plating System simplifies anterior cervical spinal fusion by accommodating three philosophies in one streamlined device.  Semi-constrained, unconstrained, and constrained options are all addressed within this single system.  One set of instrumentation and implants allow for varying degrees of constraint at the screw-plate interface.

back to top

Indication

The 3° Anterior Cervical Plating System is a temporary implant intended for anterior fixation to the cervical spine from C2 to C7.  The specific clinical indications include:

  • Degenerative disc disease (defined as back pain of discogenic origin with degenerative disc confirmed by patient history and radiographic studies)
  • Spondylolisthesis
  • Fracture
  • Spinal stenosis
  • Deformities (i.e., scoliosis, kyphosis, and/or lordosis)
  • Tumor
  • Pseudoarthrosis
  • Revision of previous surgery

back to top

Physician Benefits
Implants
Semi-constrained construct for restricted axial construct translation
Unconstrained construct for unrestricted axial construct translation
Constrained construct for rigid fixatoin at 0 degrees
Low lead-in plate profile - 1.2mm
Instrumentation
  • Innovative All-In-One Drill Guide and plate holder: drill, tap and screw through a single instrument
  • Freehand Guides are available for variable screw angle placement
  • Bone Screw Driver includes a retention mechanism that ensures complete grip and control during insertion

back to top

Contraindications
The 3° ACP System is contraindicated in patients with a systemic infection, with a local inflammation at the bone site, or with rapidly progressive joint disease or bone absorption syndromes such as Paget’s disease, osteopenia, osteoporosis, or osteomyelitis. Do not use this system in patients with known or suspected metal allergies. Use of the system is also contraindicated in patients with any other medical, surgical or psychological condition that would preclude potential benefits of internal fixation surgery such as the presence of tumors, congenital abnormalities, elevation of sedimentation rate unexplained by other disease, elevation of white blood cells or a marked shift in white blood cell differential count.

back to top

About Us | Investors | Innovation | Products | Health Professionals | Patients | Coding | Careers | Customer Service

© 2010 Orthofix Holdings Inc.